Gradalis, Inc.
Pharmaceutical company · Carrollton, Texas, United States
Gradalis, Inc. is a pharmaceutical company headquartered in Carrollton, Texas, United States. Its earliest recorded incorporation is in 2014. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $1.1 million in total, most recently in 2011. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2025.
Gradalis at a glance
What does Gradalis do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $1.1 million in total (2006 to 2011).
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $12.7 million sold (2025).
Frequently asked questions about Gradalis
Where is Gradalis headquartered?
Gradalis, Inc. is headquartered in Carrollton, Texas, United States.
What does Gradalis do?
Gradalis, Inc. is a pharmaceutical company.
When was Gradalis founded?
The earliest incorporation on record for Gradalis, Inc. is in 2014, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.